Optimind Pharma Corp. (LNE.H) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CAD 1 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.01

Return on Equity

11.86%

Price to Book

-0.55

Revenue and Profits:

Net Sales:

0 Million

(Quarterly Results - May 2025)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

0.0%

6 Months

0.0%

1 Year

0.0%

2 Years

-50.0%

3 Years

-83.33%

4 Years

0.0%

5 Years

0.0%

Optimind Pharma Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

2.66%

EBIT Growth (5y)

-1.65%

EBIT to Interest (avg)

-0.47

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.04

Sales to Capital Employed (avg)

0.08

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-0.55

EV to EBIT

-0.56

EV to EBITDA

-0.56

EV to Capital Employed

-0.56

EV to Sales

0.56

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

Bullish

Bollinger Bands

Sideways

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - May'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended May 2025 is 0.00% vs 0.00% in May 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended May 2025 is 100.00% vs 75.00% in May 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "May'25",
        "May'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.00",
          "val2": "-0.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.00",
          "val2": "-0.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-8.20%",
          "val2": "-6,075.20%",
          "chgp": "606.70%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Feb'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Feb 2025 is 0.00% vs -50.00% in Feb 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Feb 2025 is 85.71% vs 54.84% in Feb 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Feb'25",
        "Feb'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.20",
          "val2": "-0.70",
          "chgp": "71.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.50",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.20",
          "val2": "-1.40",
          "chgp": "85.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,823.20%",
          "val2": "-6,236.80%",
          "chgp": "441.36%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - May'25 - YoY

May'25

May'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-0.00

-0.10

100.00%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-0.00

-0.10

100.00%

Operating Profit Margin (Excl OI)

-8.20%

-6,075.20%

606.70%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended May 2025 is 0.00% vs 0.00% in May 2024

Consolidated Net Profit

YoY Growth in quarter ended May 2025 is 100.00% vs 75.00% in May 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Feb'25

Feb'25

Feb'24

Change(%)

Net Sales

0.10

Operating Profit (PBDIT) excl Other Income

-0.20

-0.70

71.43%

Interest

0.00

0.10

-100.00%

Exceptional Items

0.00

-0.50

100.00%

Consolidate Net Profit

-0.20

-1.40

85.71%

Operating Profit Margin (Excl OI)

-1,823.20%

-6,236.80%

441.36%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Feb 2025 is 0.00% vs -50.00% in Feb 2024

Consolidated Net Profit

YoY Growth in year ended Feb 2025 is 85.71% vs 54.84% in Feb 2024

All Annual Results

Company CV

About Optimind Pharma Corp.

Optimind Pharma Corp.

Pharmaceuticals & Biotechnology

Loon Energy Corporation is a Canada-based international oil and gas exploration and development company. The Company owns interests in certain South American oil and gas assets, which include interests in properties in Colombia that are obtained by way of farm-out agreements, and an interest in a block of exploration lands in Peru. The Company's segments include Colombia and Corporate. Through a farm-in agreement, the Company earned an non-operated participating interest in approximately 60,820 hectare block of land covered by the Buganviles Association Contract between Holywell Resources S.A. and Empresa Colombiana de Petroleos (Ecopetrol). The Company has not conducted any active oil and gas operations. The Company pursues and evaluates exploration and development opportunities in the international oil and gas arena.

Company Coordinates

Company Details

1100-700 4 Ave SW , CALGARY AB : T2P 3J4

Tel: 1 403 8752008

Registrar Details